Giant Cell Arteritis in the Arab Region With a Focus on Jordan

Fatima Al Naimat

Great Debate (PMR/GCA) - Upfront Use of IL-6 Inhibitors

Hospital for Special Surgery

R. Spiera, P. Seo

Diagnosis of Giant Cell Arteritis

Houston Methodist DeBakey Heart and Vascular Center

S. To

Abstract Discussions: Osteoporotic Fractures in Postmenopausal Women…

RheumNow

J. Pope

Steroid Tapering in PMR: What's the Gold Standard?

RheumNow

A. Dua

GCA & Steroid Weaning

RheumNow

J. Cush

Are 14-3-3 Proteins Important Antigens in Large Vessel Vasculitis?

Cleveland Clinic Rheumatology

L. Calabrese, G. Hoffman

PMR Mimics: PMR vs RA?

RheumNow

R. Spiera

When Should Biologic Agents be Introduced in Giant Cell Arteritis an…

Cleveland Clinic Rheumatology

K. Warrington

72 y/o Female With Giant Cell Arteritis, Polymyalgia Rheumatica, and…

Vanderbilt University Medical Center (VUMC)

K. Byram

Introduction to Ultrasound in Large Vessel Vasculitis - How to Corre…

University of Washington School of Medicine

W. Schmidt

Update in Rheumatology 2023 (Gout, JAK safety in RA, Dermatomyositis…

John Tesser

2023 Rheumatology Year in Review

RheumNow

J. Cush

Outcomes of COVID-19 Infection in Patients With Primary Systemic Vas…

ACR Convergence 2021 Coverage

S. Sattui Cortes

Resolution of PMR Signs and Symptoms in Patients Treated with Sarilu…

Robert Spiera

Cleveland Clinic 2020 ACR Update on GCA: Is Tocilizumab + Ultra-Shor…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

ACR Convergence 2023 Highlights: Tocilizumab vs Methotrexate in Gian…

Highlights from ACR Convergence 2023

E. Treppo

Rheumatic IO Related irAEs: Are Rheumatogists Best Equipped to Manag…

Cleveland Clinic Rheumatology

L. Calabrese

PMR: Must Rule Outs

RheumNow

L. Calabrese

The Cat in Wolves Clothing – Is It ANCA Vasculitis or Bartonella & M…

Cleveland Clinic Rheumatology

A. Brown